One potential therapeutic strategy to combat respiratory infections and inflammation has been developed from understanding the functional roles of mammalian serine threonine protein kinases Map2k1 (MEK1) and Map2k2 (MEK2). The gene discussed is MAP2K2; the disease is respiratory tract infectious disorder.